
Organization · Holding Company
Novo Holdings
Novo Holdings is a Danish holding and investment company based in Copenhagen, managing the assets of the Novo Nordisk Foundation. It focuses on life sciences investments across various stages and sectors.
Overview
What Novo Holdings does
What Novo Holdings is
Novo Holdings is a Danish holding and investment company based in Copenhagen, managing the assets of the Novo Nordisk Foundation. It focuses on life sciences investments across various stages and sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Holding Company
- Founded
- Founded in 1999
- Approximate age
- About 27 years
- Structured capabilities
- Funder
- Last reviewed
- March 16, 2026
Official channels
Find Novo Holdings elsewhere
Open the official website or a supported primary organization account.
Capability profile
Novo Holdings as a funder
Investment thesis
Novo Holdings aims to improve health and sustainability by generating long-term returns on the assets of the Novo Nordisk Foundation.
Focus narrative
Novo Holdings primarily invests in life science companies across all development stages, including pharmaceuticals, biotechnology, medical technology, and healthcare services. The organization also manages a diverse portfolio that includes equities, bonds, real estate, and private equity, focusing on generating attractive long-term returns and positive societal impact.
Value beyond capital
Novo Holdings adds value to its portfolio companies through a hands-on approach, ensuring optimal conditions for success and promoting groundbreaking solutions in healthcare and bio-sustainability.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- KabaFusion and Elektrofi
Portfolio context
Notable investments include Surya Hospitals, the largest private women's and children's specialty hospital chain in Western India; KabaFusion, a provider of chronic and acute infusion therapies; Elektrofi, a biopharmaceutical company acquired by Halozyme; Kivu Bioscience, which raised $92 million in Series A financing; and CIRCTEC, a leader in sustainable tyre recycling that raised €150 million.
Connected ecosystem
Continue from Novo Holdings
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Novo Holdings
Upseed classifies Novo Holdings under the Holding Company organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.